| Questcor Pharmaceuticals CEO Discusses Q1 2011 Results - Earnings Call Transcript - Seeking Alpha |
|
|
Seeking Alpha Now I will discuss our progress in nephrology. We saw early positive results from our 5% nephrology sales team. We hope to generate the highest number of Acthar prescriptions in nephrotic syndrome of any quarters so far. The 18 scripts in the quarter, |